Research on antibodies and their uses. Covers engineered antitoxin antibodies, long-lasting immunity, monoclonal therapies, and antiviral T cells.
Research found that thalassemic patients had a higher prevalence of anti-HAV IgG antibodies than healthy controls. This is unexpected, as previous studies showed lower rates in thalassemics. The study recommends active immunization for transfused thalassemia patients to reduce liver infections.
Researchers at the University of Michigan discovered a link between specific antibodies and oral health, finding that healthy individuals have higher antibody levels to a key protein in periodontal disease. This discovery could lead to improved treatment responses and prevention strategies.
Researchers in Uganda have discovered a new orthopoxvirus in red colobus monkeys, similar to those causing monkeypox and cowpox. The finding highlights the potential for unknown pathogens to emerge in wildlife and pose risks to human health.
Researchers at the University of Illinois have developed a new technique to image cells under an electron microscope, yielding a sharper picture of chromatin structure. This method allows for enhanced staining and structural preservation, enabling scientists to study chromatin packing and gene expression in high resolution.
A simple and fast screening technique has been developed to identify promising synthetic molecules that mimic therapeutic antibodies and can treat cancer at a lower cost. The new method screened over 300,000 peptoids and isolated five candidates that showed promise in treating human tumors.
A study published in Arthritis Research & Therapy found that a gluten-free vegan diet can lower cholesterol and oxidized LDL levels, while raising natural antibodies against phosphorylcholine in patients with rheumatoid arthritis. This may help protect against heart attacks and stroke.
New DNA vaccine data identified in mice shows increased immune response by targeting HIV protein gp41 to DCs with a single-chain Fv antibody. This approach induced stronger T cell responses and protected mice from the virus more efficiently than current DNA vaccines.
New DNA vaccine technology targets DCs for enhanced immune response; studies in mice show improved protection against viruses and potential applications for cystic fibrosis modeling. Genetic manipulation creates large animal models of CF, providing new avenues for disease research.
Researchers at ETH Zurich have developed a novel antibody test that can detect specific antibodies against Plasmodium falciparum's toxic sugar molecules. This test has the potential to protect adults from severe malaria and could also be used to develop a selective vaccine for infants under 5, who are most vulnerable to the disease.
A recent study published in the Journal of Neuroimmunology found that mothers of autistic children may produce antibodies against their fetuses' brain tissue, which can cause changes leading to autism. The study suggests an association between maternal antibody production and developmental regression in children with autism.
Scientists from University of Chicago Medical Center report that moving active genes to nucleus periphery can silence them, preventing transcription. This novel form of gene regulation involves attachment to inner nuclear membrane, blocking transcription through proteins residing on the membrane.
A study by UC-Davis researchers found that antibodies in mothers of children with autism bind to fetal brain cells, potentially disrupting healthy development. The findings suggest a possible link between the maternal immune system and autism risk, paving the way for future research on prenatal identification and prevention.
Researchers found that lower transmission rates increase dengue deaths by reducing the development of immunity to new strains during a critical cross-immunity period. This allows the virus to gain entry into cells and cause more severe infections.
Researchers found that breakdown of self-cleaning mechanism in kidneys can lead to dysfunction and disease. The study suggests that defects in this clearance mechanism can cause accumulation of toxic substances, such as autoimmune antibodies, which can damage the kidney.
Researchers at Yale University found that an antibody used to treat certain cancers and rheumatoid arthritis delays type 1 diabetes in mice. The treatment works by depleting B cells, which can continue to suppress the inflammatory response even after the antibody is no longer administered.
Researchers have identified immunomodulatory anticancer drugs lenalidomide and pomalidomide as effective therapies for inducing fetal hemoglobin production in sickle-cell disease patients. Additionally, a new compound has been discovered to treat protein-losing enteropathy, a condition causing excessive protein loss from the gut.
HIV-infected children in Central Africa show low levels of antibodies to vaccines after childhood immunization. Researchers suggest adapted vaccine schedules may be needed for HIV-exposed infants.
A new vaccine targeting angiotensin II has shown promising results in reducing blood pressure in a small study. The vaccine produced strong antibody responses and significantly lowered systolic and diastolic blood pressures in patients with mild-to-moderate high blood pressure.
Researchers found that ABO-incompatible infant heart transplantation is as safe as transplantation with compatible blood group types. The study suggests that this procedure could significantly reduce the number of infants who die while waiting for a donor heart, with mortality rates potentially decreasing by up to 20%.
Researchers found an antibody against placental growth factor (PlGF) blocks tumor growth and enhances chemotherapy effects in mice. The antibody has a better safety profile than VEGF inhibitors, which cause severe side effects.
Scientists at Newcastle University have developed a technology using UV light to activate antibodies specifically targeting tumour cells. The cloaked antibodies can be used alone or in combination with existing antibodies, minimizing side effects and maximizing destruction of tumours.
David Spiegel, a Yale chemist, has received a $1.5 million NIH Director's New Innovator Award to develop a 'rational' approach for using antibodies to target various cells and diseases. He aims to design DNP-compounds that recognize pathogens and attract anti-DNP antibodies, destroying diseased cells.
Research suggests viruses like Human Ad-36 may play a role in causing obesity in humans, with evidence showing weight gain and fat storage in infected animals. Studies also found connections between viral infections and obesity in human subjects, including exposure to the Ad-36 virus.
Researchers at Duke University Medical Center analyzed 8,300 heart surgery patients and found no association between transfused female plasma and adverse outcomes, even a potential protective effect.
Researchers at Mayo Clinic have discovered an antibody that can repair the damaged myelin sheath in laboratory mouse models, a crucial step towards treating multiple sclerosis and related disorders. The antibody promotes remyelination with a single dose, paving the way for potential new treatments.
Researchers at Saint Louis University have found an injectable antibody that can reverse learning problems in mice with an animal version of Alzheimer's disease. The antibody, part of the IgM class, targets amyloid beta protein and prevents it from becoming toxic.
Researchers found that combining Lactobacillus rhamnosus GG probiotic strain with lower doses of hyperimmune bovine colostrum (HBC) provides protection against rotavirus infection, effective as high-dose HBC alone. This combination therapy could help relieve the immense disease burden posed by rotavirus in developing countries.
Researchers at UT Southwestern Medical Center have identified a likely cause of kidney transplant rejection: antibodies attacking MICA antigens. The study found that patients who showed the most marked effect from these antibodies were those considered high-risk for clinical transplantation.
Researchers have identified radial spoke protein 44 (RSP44) as a key molecule in immune infertility, a condition causing the immune system to attack sperm. The discovery may lead to new diagnostic tools and treatments for this condition, which affects up to 12% of unexplained infertility cases in women.
Researchers discovered that first-degree relatives of PBC patients have a higher prevalence of anti-mitochondrial antibodies, a biomarker indicative of the disease. This finding enables early screening and assessment of high-risk family members through simple blood tests, potentially leading to better outcomes for PBC patients.
Research finds patients with lower levels of HCV antibody titer tend to have a brighter clinical outcome. Co-infection by hepatitis B and A viruses is associated with a higher possibility of self recovery, possibly due to interference with virus replication.
Scientists from around the world present convergent views on the 'memory of water' concept, which suggests that water can display memory effects. Researchers found large-scale structural changes in liquid water, potentially accounting for claims of memory of water effects.
A new study found that blacks with multiple sclerosis have significantly higher levels of an antibody in their spinal fluid than Caucasians, suggesting genetic factors contribute to the difference. The discovery may help explain why black patients are more likely to experience severe symptoms when they develop MS.
Researchers have found that treating mice with tularemia-specific antibodies can protect them against the bacteria, enhancing immune responses and acting as a surrogate vaccine. This approach could be particularly useful in cases of bioterrorism, providing rapid and specific protection to individuals with weakened immune systems.
Researchers have made promising breakthroughs in understanding how antibodies can reduce the main hallmarks of Alzheimer's disease, including memory loss and ability to learn. The study suggests that antibodies could be used to prevent protein clusters from forming, which is believed to kill nerve cells.
Researchers identified naturally occurring antibodies in human blood that selectively target toxic beta amyloid oligomers, potentially offering a natural defense mechanism against Alzheimer's. The antibodies recognize misfolded shapes of proteins, which could have implications for immune therapy of other neurodegenerative diseases.
The study found that antibodies against arthropod saliva can indicate exposure to bites, allowing for improved assessment of disease transmission risk in endemic areas. This research aims to develop simple and effective prevention tools using immunogenic salivary proteins.
A study by Weill Cornell Medical College researchers found that immune antibodies penetrate neurons and reduce levels of Alzheimer's-linked amyloid peptides, offering new hope for immunotherapy against the disease. The discovery could also advance treatment for other immune diseases.
A research team developed an engineered protein that effectively neutralizes Staphylococcus aureus toxin, preventing symptoms in rabbits and reversing illness after exposure. The protein has potential advantages over antibodies, including smaller size and faster clearance from the body.
Scientists at Dana-Farber Cancer Institute have discovered a new approach to treating autoimmune diseases such as multiple sclerosis. By blocking a key interaction between immune cells, they found that one type of cell is attacked and dies, suggesting a potential therapy for various immunological conditions.
Researchers have successfully used specific antibodies to differentiate between fingerprints of smokers and nonsmokers, detecting cotinine metabolite in sweat. This technique could be used for forensic applications, doping detection, medical diagnostics, and drug screening without taking blood samples.
Researchers at La Jolla Institute for Allergy & Immunology have made an important finding on cytomegalovirus transmission by reducing the virus in salivary glands using antibodies. The study may have implications for other chronic virus infections like hepatitis and HIV.
Researchers have developed an oral vaccine that can prevent mice from developing brain diseases similar to mad cow disease. The vaccine stimulates the immune system, resulting in delayed onset of symptoms even in mice with low antibody levels.
A study of 34 children with autism compared to 34 without autism found no connection between the two conditions. Researchers looked for specific antibodies associated with celiac disease, but none were found in autistic children.
Researchers at the University of Texas at Austin have developed a faster approach to producing disease-fighting antibodies. This method can provide significant time savings and enable the isolation of therapeutic antibodies for human diseases that were previously unobtainable.
Researchers from Massachusetts General Hospital and MIT found that self-management tools reduce medical costs and improve treatment quality. Examples of such tools include patient-controlled insulin dosing and medication adjustments based on symptoms.
Researchers at Emory University have developed an algorithm that can predict which sensitized patients on the national waiting list for kidney transplants are compatible with a given donor. This new method, based on innovative technology, has increased transplant rates from 15% to 25% in highly sensitized patients.
Scientists at UCLA's Jules Stein Eye Institute have discovered defects in the infection-fighting T-cells of Graves' disease (GD) patients' immune systems. The study found an abnormal surplus of receptors targeted by an antibody that mistakenly attacks the thyroid gland, causing inflammation and damage to eye tissue.
Researchers develop biodegradable vaccine delivery system that stimulates cellular-mediated immunity and enhances antibody response. The microsphere formulation could lead to single-dose vaccines for diseases requiring booster shots.
Researchers found a close correlation between vancomycin exposure and severe thrombocytopenia with serious bleeding. The antibiotic was discontinued in most cases, resulting in normal platelet counts.
Researchers at St. Jude Children's Research Hospital found that the N1 protein in seasonal flu vaccines can trigger an antibody response to avian flu virus, offering cross-protection to some individuals. The study suggests that annual influenza vaccines may be beneficial to populations in areas where H5N1 poses a threat to humans.
A study published in PLoS Medicine found that some people have low-titer antibodies against H5N1 influenza, suggesting potential protection. The researchers also observed cross-reactive antibodies in mice, which afforded partial protection against avian H5N1 infection.
Researchers at Yale University discovered a potential reversible cause of first-degree fetal heart block, which impairs the heart's electrical signaling. The PRIDE study found that early treatment with dexamethasone can reverse the condition, but it can progress rapidly to irreversible third-degree block.
Researchers at NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases found that up to 10% of B cells retain faulty receptors, escaping correction. This discovery sheds light on the development of self-reactive B cells in autoimmune disease.
Researchers at Yale University have developed a novel approach to synthesizing nanowires, allowing them to integrate with microelectronic systems and act as highly sensitive biomolecule detectors. This breakthrough has profound implications for the application of nanoscience technologies and future diagnostics.
A new EGFR antibody shows promise in treating lung cancer by targeting activated receptors. In a mouse model, the antibody caused significant tumor regression where cetuximab failed.
Researchers have successfully produced proteins that resemble antibodies in plant seeds, demonstrating their potential for therapeutic and diagnostic applications. The antibody variants are just as active as whole antibodies and can be used in medical applications, with advantages including high production capacity and timely processing.
Researchers at St. Jude Children's Research Hospital found that harvesting aggressive stem cells from donated bone marrow can reduce the time it takes for a child's immune system to rebuild after a bone marrow transplant. This could lead to lower risk of fatal virus infections and improved long-term outcomes.
Research suggests that common painkillers like NSAIDs can reduce vaccine effectiveness by reducing antibody production. The study's findings have implications for people who take these medications regularly, particularly those with compromised immune systems.
Researchers have created a diagnostic test that can detect viruses like influenza, HIV, and RSV in under 60 seconds using surface-enhanced Raman spectroscopy (SERS). The technique works by measuring the change in frequency of a near-infrared laser as it scatters off viral DNA or RNA.